Physician profile
John Park
NPI 1083690200
$7,440.37
in general payments reported to CMS, 2019-2025
25 companies · $428 in 2025
The $428 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,281 · 2020: $3,075 · 2021: $344 · 2022: $396 · 2023: $496 · 2024: $421 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,344.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,926.89 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $580.08 | 2019-2025 | Gattex, Entyvio |
| Medtronic, INC. | $469.73 | 2021-2025 | Interstim, Ligasure |
| Ferring Pharmaceuticals INC. | $298.54 | 2019-2024 | Clenpiq, Rebyota |
| Braintree Laboratories, INC. | $192.82 | 2020-2024 | Suflave, Sutab |
| Ethicon US, LLC | $150.00 | 2025 | Echelon Endopath, Echelon Flex, Enseal X1 |
| Axonics, INC. | $97.17 | 2020-2023 | Axonics |
| Shire North American Group INC | $90.72 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $81.48 | 2019-2022 | |
| Exact Sciences Corporation | $75.98 | 2025 | Cologuard Collection Kit |
| Integra Lifesciences Corporation | $70.23 | 2021-2022 | |
| Abbvie INC. | $56.19 | 2025 | |
| Kerecis Limited | $49.96 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Trevena, INC. | $47.88 | 2022 | |
| Laborie Medical Technologies Corp. | $43.94 | 2025 | Solar Compact |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $33.34 | 2023-2024 | Irrisept |
| Becton, Dickinson and Company | $30.96 | 2025 | Surgiphor |
| Merck Sharp & Dohme LLC | $28.70 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $25.44 | 2024 | Voquezna |
| Pacira Pharmaceuticals Incorporated | $24.42 | 2022 | |
| Kci USA, INC. | $20.27 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Aimmune Therapeutics, INC. | $14.05 | 2025 | Zenpep |
| Covidien LP | $12.82 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.90 | 2019 | |
| Thd America, INC. | $6.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.